These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10451159)

  • 1. Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program--Active (IMPACT).
    Halperin SA; Wang EE; Law B; Mills E; Morris R; Déry P; Lebel M; MacDonald N; Jadavji T; Vaudry W; Scheifele D; Delage G; Duclos P
    Clin Infect Dis; 1999 Jun; 28(6):1238-43. PubMed ID: 10451159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of changing from whole-cell to acellular pertussis vaccine on the epidemiology of hospitalized children with pertussis in Canada.
    Bettinger JA; Halperin SA; De Serres G; Scheifele DW; Tam T
    Pediatr Infect Dis J; 2007 Jan; 26(1):31-5. PubMed ID: 17195702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in Canada.
    Mikelova LK; Halperin SA; Scheifele D; Smith B; Ford-Jones E; Vaudry W; Jadavji T; Law B; Moore D;
    J Pediatr; 2003 Nov; 143(5):576-81. PubMed ID: 14615725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pertussis deaths: report of 23 cases in the United States, 1992 and 1993.
    Wortis N; Strebel PM; Wharton M; Bardenheier B; Hardy IR
    Pediatrics; 1996 May; 97(5):607-12. PubMed ID: 8628595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
    Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S
    CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis in the young infant.
    Hampl SD; Olson LC
    Semin Respir Infect; 1995 Mar; 10(1):58-62. PubMed ID: 7761715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the vaccination coverage established enough to control pertussis, or it is a re-emerging disease?
    Cardeñosa N; Romero M; Quesada M; Oviedo M; Carmona G; Codina G; Jansà JM; Domínguez A;
    Vaccine; 2009 May; 27(25-26):3489-91. PubMed ID: 19200822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of routine vaccination with a pertussis toxoid vaccine in Denmark.
    Hviid A; Stellfeld M; Andersen PH; Wohlfahrt J; Melbye M
    Vaccine; 2004 Sep; 22(27-28):3530-4. PubMed ID: 15315832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands.
    de Greeff SC; Mooi FR; Schellekens JF; de Melker HE
    Pediatr Infect Dis J; 2008 Mar; 27(3):218-23. PubMed ID: 18277916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Whooping cough in the first year of life in a region with high vaccination coverage].
    Aristimuño H; Muga O; Cilla G; Piñeiro L; Zapico MS; Pérez-Yarza EG
    An Pediatr (Barc); 2011 Sep; 75(3):194-8. PubMed ID: 21531640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
    Gustafsson L; Hessel L; Storsaeter J; Olin P
    Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of pertussis hospitalizations among Japanese infants: excess hospitalizations and complications?
    Takeuchi M; Yasunaga H; Horiguchi H; Matsuda S
    Epidemiol Infect; 2012 Aug; 140(8):1497-502. PubMed ID: 22008091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher pertussis hospitalization rates in indigenous Australian infants, and delayed vaccination.
    Kolos V; Menzies R; McIntyre P
    Vaccine; 2007 Jan; 25(4):588-90. PubMed ID: 16971026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pertussis: a reemerging infection?].
    Kriz B; Fabiánová K; Maixnerová M; Benes C; Malý M
    Epidemiol Mikrobiol Imunol; 2007 Apr; 56(2):51-65. PubMed ID: 17593802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology of children hospitalized with herpes zoster in Canada: Immunization Monitoring Program, Active (IMPACT), 1991-2005.
    Wootton SH; Law B; Tan B; Mozel M; Scheifele DW; Halperin S;
    Pediatr Infect Dis J; 2008 Feb; 27(2):112-8. PubMed ID: 18174867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pertussis hospitalizations among infants in the United States, 1993 to 2004.
    Cortese MM; Baughman AL; Zhang R; Srivastava PU; Wallace GS
    Pediatrics; 2008 Mar; 121(3):484-92. PubMed ID: 18310196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pertussis hospitalisations: Northern Region of Portugal, 2000-2006].
    Vieira M; Dias JG; Queirós L; Correia AM
    Acta Med Port; 2010; 23(4):605-12. PubMed ID: 20687988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case-control study of vaccination history in relation to pertussis risk during an outbreak among school students.
    Khan FN; Lin M; Hinkle CJ; Franklin P; Luther R; Woodruff F; Henson K; Lukenbill M; Gutierrez M; Zhu BP
    Pediatr Infect Dis J; 2006 Dec; 25(12):1132-6. PubMed ID: 17133158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The changing age and seasonal profile of pertussis in Canada.
    Skowronski DM; De Serres G; MacDonald D; Wu W; Shaw C; Macnabb J; Champagne S; Patrick DM; Halperin SA
    J Infect Dis; 2002 May; 185(10):1448-53. PubMed ID: 11992280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.